Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Seizes Tissue Valve Firm’s Entire Product Line, Citing Sterilization Issues

This article was originally published in The Gray Sheet

Executive Summary

U.S. marshals confiscated all devices manufactured by New Jersey-based Shelhigh in an April 17 seizure resulting from FDA concerns with product sterility

You may also be interested in...



FDA Follows Up Shelhigh Seizure With Formal Request For Recall

FDA is leaning on tissue product manufacturer Shelhigh to recall its entire product line after all inventory at its manufacturing facility was seized by federal marshals last month

FDA Follows Up Shelhigh Seizure With Formal Request For Recall

FDA is leaning on tissue product manufacturer Shelhigh to recall its entire product line after all inventory at its manufacturing facility was seized by federal marshals last month

FDA Announces Two More Medical Device Consent Decrees

FDA has already completed three consent decrees blocking sales of medical devices in 2007, with two surfacing last week. The agency has not obtained more than two device-related injunctions in any of the previous six years

Related Content

UsernamePublicRestriction

Register

MT024708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel